Marea reports positive Phase I results for MAR002 trial in acromegaly
Single-ascending doses of MAR002 showed a favourable tolerability and safety profile with no drug-related safety signals observed.
Clinical Trials
AbCellera begins Phase II ABCL635 trial for menopause-related VMS
BMS reports positive results in Phase III SCOUT-HCM trial for oHCM
UK introduces clinical trial regulatory reforms to enhance research appeal
MRM Health receives FDA clearance for STARFISH-UC Phase IIb trial
GRIN Therapeutics begins Phase III trial of radiprodil for NDD
NRG doses first participants in Phase I trial for ALS and Parkinson’s
Mount Sinai introduces PRISM platform for trial matching
